Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China flag China · Delayed Price · Currency is CNY
6.68
+0.01 (0.15%)
At close: Feb 13, 2026

SHA:600222 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
343.86180.04196.67311.38380.55487.32
Trading Asset Securities
-80.02153.374.96285.67207.46
Cash & Short-Term Investments
343.86260.05349.97386.34666.22694.78
Cash Growth
-13.55%-25.69%-9.41%-42.01%-4.11%20.92%
Accounts Receivable
1,2301,1371,0561,038744.71689.25
Other Receivables
32.7736.3844.0151.1556.4478.65
Receivables
1,2631,1731,1001,089801.15767.89
Inventory
478.7367.67455.5450.49381.85348.14
Other Current Assets
113.37105.3587.88105.0394.4971.56
Total Current Assets
2,1991,9061,9932,0311,9441,882
Property, Plant & Equipment
483.21501.82529.65551.13539.58494.09
Long-Term Investments
506.4526.67520.38490.93825.63533.76
Goodwill
286.49286.49286.49286.49286.49286.49
Other Intangible Assets
50.3451.1752.548.1153.157.54
Long-Term Deferred Tax Assets
114.04113.294.2495.3852.447.16
Long-Term Deferred Charges
48.0552.849.8154.2335.8132.98
Other Long-Term Assets
50.8351.5550.7149.0847.0554.99
Total Assets
3,7383,4903,5773,6073,7843,389
Accounts Payable
343294.89470.29548.89355.65211.71
Accrued Expenses
6.5328.2624.2732.2222.4520.56
Short-Term Debt
638.59663.42381.84404.87973.58750.22
Current Portion of Long-Term Debt
123.01270.0789.764.22158.74406.21
Current Portion of Leases
-46.2935.3526.89--
Current Income Taxes Payable
9.761.282.5321.863.72.98
Current Unearned Revenue
5.946.5411.6288.2649.4761.27
Other Current Liabilities
776.46483.76634.5598.8286.0950.94
Total Current Liabilities
1,9031,7951,6501,7261,6501,504
Long-Term Debt
134.873.02183.8192.820.37136.38
Long-Term Leases
28.2942.0489.2937.1472.0631.6
Long-Term Unearned Revenue
2.532.783.261.71--
Long-Term Deferred Tax Liabilities
19.8421.1625.3633.26132.4256.96
Other Long-Term Liabilities
--1.621.62131.62130
Total Liabilities
2,0891,8641,9531,9932,0061,859
Common Stock
573.89573.89573.89573.89573.89573.89
Additional Paid-In Capital
675.17675.17675.17675.17588.14588.14
Retained Earnings
360.71316.01281.01237.46232.15235.16
Treasury Stock
-109.8-101.01-79.72-37.66-48.7-98.47
Comprehensive Income & Other
92.86110.67128.15121.56315.04154.7
Total Common Equity
1,5931,5751,5781,5701,6611,453
Minority Interest
56.6651.5144.8943.62117.1377.16
Shareholders' Equity
1,6491,6261,6231,6141,7781,531
Total Liabilities & Equity
3,7383,4903,5773,6073,7843,389
Total Debt
924.761,025780.03665.921,2251,324
Net Cash (Debt)
-580.9-764.79-430.07-279.58-558.53-629.62
Net Cash Per Share
-1.05-1.37-0.76-0.50-1.00-1.15
Filing Date Shares Outstanding
552.92554.67559.36566.69563.04545.98
Total Common Shares Outstanding
552.92554.67559.36566.69563.04545.98
Working Capital
295.65111.55342.93305.21294.03378.49
Book Value Per Share
2.882.842.822.772.952.66
Tangible Book Value
1,2561,2371,2391,2361,3211,109
Tangible Book Value Per Share
2.272.232.222.182.352.03
Buildings
-556.93543.26534.9520.76516.81
Machinery
-361.45341.92316.19281.14247.95
Construction In Progress
-29.228.931.133.0224.31
Source: S&P Global Market Intelligence. Standard template. Financial Sources.